The interaction between metabolism and the immune system plays a central role in many cardiometabolic diseases. We integrated blood transcriptomic, metabolomic, and genomic profiles from two population-based cohorts, including a subset with 7-year follow-up sampling. We identified topologically robust gene networks enriched for diverse immune functions including cytotoxicity, viral response, B cell, platelet, neutrophil, and mast cell/basophil activity. These immune gene modules showed complex patterns of association with 158 circulating metabolites, including lipoprotein subclasses, lipids, fatty acids, amino acids, and CRP. Genome-wide scans for module expression quantitative trait loci (mQTLs) revealed five modules with mQTLs of both cis and trans effects. The strongest mQTL was in ARHGEF3 (rs1354034) and affected a module enriched for platelet function.
Introduction
Over the last decade increasing evidence has implicated inflammation as a probable causal factor in metabolic and cardiovascular diseases. Consequently, research has begun to focus on the interplay between immunity and metabolism, or immunometabolism. While it is involved in diverse pathophysiologies, immunometabolism is particularly relevant to diseases of immense global health burden, such as type 2 diabetes (T2D) and atherosclerosis.
For T2D, immune overactivation in adipose tissue has been implicated as a key driver (1, 2) . Studies have shown that macrophage infiltration and subsequent overexpression of proinflammatory cytokines, such as TNF-a, in adipose tissues is associated with insulin resistance (1, 2) . Moreover, evidence for metabolic inflammation has been shown in other tissues where, in blood, elevated glucose and free fatty acid levels potentiate IL-1β mediated destruction of pancreatic ß-cells and subsequent T2D progression (3) (4) (5) . While circulating metabolites are known to be associated with cardiovascular disease (6) , inflammation is an increasingly recognised factor in pathogenesis. In atherosclerosis, lipidinduced inflammatory response mechanisms have also been implicated in progression to myocardial infarction (7) . In atherogenic lesions, oxidized phospholipids are known to lead to a new macrophage phenotype (8) , and cholesterol loading in macrophages promote proinflammatory cytokine secretion (9) .
Perhaps surprisingly, few large-scale studies have systematically assessed interactions between the human immune system and metabolites. Recent studies have investigated matched blood transcriptomic and metabolomic profiles to understand their interplay (10) (11) (12) (13) (14) (15) (16) . However, these studies had modest sample sizes and thus have not had the power to focus on the diverse range of immune processes that interact with circulating metabolites. Furthermore, even fewer have assessed effects of expression quantitative trait locus (eQTL) on immune gene networks. A robust integrated map of immunometabolic relationships and their genetic regulation would provide a foundation for investigating the differential cardiometabolic disease susceptibility amongst individuals while also identifying key target interactions for mechanistic in vivo and in vitro follow-up.
In this study, we present an integrated immunometabolic map using matched blood metabolomic and transcriptomic profiles from 2,168 individuals from two population-based cohorts. We perform gene coexpression network discovery and cross-cohort replication to identify robust gene modules which encode immune-related functions. Using a high-throughput quantitative NMR metabolomics platform that can separate lipids and lipoprotein sub-fractions as well as quantify a panel of polar metabolites, we identify significant interactions between immune gene modules and circulating metabolites.
Genome-wide scans for QTLs affecting immune gene modules identify many cis and trans loci affecting module expression. Finally, we test the long-term stability of gene modules, their metabolite interactions, and genetic control using a 7-year follow up sampling of 333 individuals.
Results and Discussion

Summary of cohorts and data
We analysed genome-wide genotype, whole blood transcriptomic and serum metabolomics data from two population-based cohorts (Methods and Figure 1 ). In DILGOM07, 240 males and 278 females aged 25-74 years were recruited (total N = 518). Data was available for a subset of 333 participants from DILGOM07 who were followed up after seven years (DILGOM14). In YFS, relevant data was available for 755 males and 895 females aged 34-49 years (total N = 1,650). DILGOM and YFS genotyping was performed using Illumina Human 610 and 670 arrays, respectively, with subsequent genotype imputation performed using IMPUTE2 (17) and the 1000 Genomes Phase I version 3 reference panel. For both cohorts, whole blood transcriptome profiling was performed using Illumina HT-12 arrays and serum metabolomics profiling was carried out using the same serum NMR metabolomics platform (Brainshake, Ltd) (18) . Individuals on lipid-lowering medication and pregnant women were excluded from the metabolome analyses (Methods). Of the 158 metabolites analysed, 148 were directly quantified and 10 derived (Table S1 ). After filtering, matched transcriptome and metabolome data was available for 440 individuals in DILGOM07 and 216 of these individuals (DILGOM14) who were profiled at seven-year follow-up. In YFS, 1,575 individuals were available with similar data (see Methods for details).
Robust immune gene coexpression networks from blood
We first identified networks of tightly coexpressing genes in DILGOM07 and then used a permutation approach, NetRep (19) , to statistically test replication patterns of density and connectivity for these networks in YFS. For module detection, we applied weighted gene coexpression network analysis (WGCNA) to all 35,422 probes in the DILGOM07 data, identifying a total of 40 modules of coexpressed genes (Methods). For each module, we used NetRep to calculate seven preservation statistics in the YFS, generate empirical null distributions for each of these test statistics, and calculate their corresponding P-values (19, 20) . A module was considered strongly preserved if the P was < 0.001 for all seven preservation statistics (Bonferroni correction for 40 modules). Of the 40 DILGOM07 modules, 20 were strongly preserved in YFS (Table S2) . For each of the 20 replicated modules, we defined core gene probes, those which are most tightly coexpressed and thus robust to clustering parameters, using a permutation test of module membership (Methods and Table S3 ).
To identify modules of putative immune function, we carried out Gene Ontology (GO) biological process enrichment analysis using GOrilla for the core genes of each replicated module (21) .
Significant GO terms (FDR < 0.05) were then summarised into representative terms based on semantic similarity using REVIGO (22) (Figure S1) . A module was considered immune related if it was significantly enriched for GO terms "immune system processes" (GO: 0002376) and/or "regulation of immune system processes" (GO:0002682) in the REVIGO output. Six out of 20 modules were enriched for at least one of these terms (Table S4) . We also identified two additional modules, which were not enriched for any GO terms, but have been previously linked to immune functions related to mast cell and basophil function (13) and platelet aggregation activity (23) . The eight modules encoded diverse immune functions, including cytotoxic, viral response, B cell, platelet, neutrophil, mast cell/basophil, and general immune-related functions. Each immune module's gene content and putative biological function is summarized in Table 1 .
Immune module association analysis for eQTLs and metabolite levels
For each gene module, we performed a genome-wide scan to identify module QTLs (mQTLs) that regulate expression. In DILGOM07 and YFS, the module eigengene was regressed on each SNP, then mQTL test statistics were combined in meta-analysis (Methods). Significant mQTLs were further examined at individual gene expression levels. A genome-wide significance level (P-value < 5x10 -8 ) was used to identify mQTLs and significant trans effects on individual gene expression ( Figure 2 and Table 2 ). Leukocyte and platelet counts were available for YFS and were used to test the robustness of module associations with mQTLs and metabolites. Six modules showed statistically significant association with platelet or leukocyte counts (P-value < 0.05) (Table S5) , however adjustment for leukocyte counts did not affect mQTL nor metabolite-module associations, with the exception of the PM and CCLM discussed below (Table S6 ). Since we did not have cell counts available for DILGOM07, all the immune-metabolite associations discussed below, unless otherwise noted, have not been adjusted for cell counts.
Cytotoxic cell-like module (CCLM)
CCLM was associated with 24 metabolites, mainly consisting of fatty acids, intermediate density lipoproteins, and CRP (Figure 3 and Table S7 ). The top associated metabolite was the average number of double bonds in a fatty acid chain (meta-P-value = 7.23 x 10 -7 ). It is known that CRP augments cytotoxic responses by binding to NK cells, modulating their activity (24) , enhancing cytotoxic responses of NK cells against tumour cells (25) , and sensitizing endothelial cells to cytotoxic T-cell mediated destruction (26) . The interaction between fatty acid double bond saturation and antiinflammatory response is well characterised, and unsaturated fatty acids have been shown to induce cytotoxicity in in vitro cancer cell lines as well as animal models of tumour incidence and growth (27, 28) . Adjustment of CCLM-metabolite associations for leukocyte counts resulted in the gain of 38 additional associations and loss of four (creatinine, ratio of polyunsaturated fatty acids to total fatty acids, VLDL particle size, and CRP) existing associations (Table S6 ). CCLM had no significant mQTLs.
Viral response module (VRM)
Three genome-wide significant mQTLs were identified for the VRM (Figure 2 and Table 2 ). The strongest mQTL, rs182710579 (meta-P-value = 9.22 x 10 -9 ), is within a known lincRNA locus (RP11-608O21.1) ( Figure S2A ). Rs182710579 was a trans eQTL for 3 genes in the VRM ( Table S8 ). The strongest association was seen with CCL2 (meta-P-value = 6.78 x 10 -12 ), a pro-inflammatory chemokine involved in leukocyte recruitment during viral infection (29, 30) . The next strongest mQTL, rs151234502, resides within intron 4 of the relatively unstudied ZNF212, part of a zinc finger gene cluster at 7q36 ( Figure S2B ). Rs151234502 modulated expression of 11 VRM genes in trans (Table   S8 ). The strongest association was with OAS2 (meta-P-value = 8.98 x 10 -10 ), an interferon-induced gene encoding an enzyme promoting RNase L-mediated cleavage of viral and cellular RNA (31) . The third mQTL, rs147742798, was an intergenic SNP located between SHANK2 and DHCR7 at 11q13.4 ( Figure S2C ). Rs147742798 was a trans eQTL for 2 genes in the VRM, BST2 and PARP9 (Table S8) .
BST2 encodes a trans membrane protein with interferon-inducible antiviral function (32) . Studies have previously shown induction of fatty acid biosynthesis by a range of viruses (33) . VRM was associated with eight metabolites, including amino acids (alanine, phenylalanine), fatty acids (omega-6 fatty acids, polyunsaturated fatty acids, saturated fatty acids, and total fatty acids), and cholesterol esters in medium VLDL (Figure 4 and Table S7 ). Consistent with its putative role in viral response, VRM was strongly associated with CRP (meta P-value = 2.38 x 10 -10 ).
B cell activity module (BCM)
The BCM was associated with 14 metabolites including CRP, histidine, lactate, apolipoprotiens, and mainly medium HDL subclass of lipoproteins. (Figure 3 and Table S7 ). The strongest association was seen with CRP (meta-P-value = 2.65 x 10 -8 ). Histidine, the second most strongly associated metabolite, is catabolized to histamine by histidine decarboxylase. The relationship between B cells and histamine is a central part of the allergic reaction where IgE released by B cells blankets mast cells, causing them to release histamine. While no mQTLs for BCM reached genome-wide significance, there was some evidence in the YFS for the MHC class I locus (Figure 2 and Table 2 ). The top signal was located between HLA-B/C and MICA (rs2523489, meta-P-value = 6.27 x 10 -8 ) ( Figure S3 ). The HLA class I region is well-known to be associated with autoimmune diseases, where the role of B cells is well recognized Rs2523489 was a trans eQTL for CD79B (meta-P-value = 1.16 x 10 -9 ), a subunit of the antigen-binding B cell receptor complex (34) .
Platelet module (PM)
PM had the strongest mQTL of any gene module, an intronic SNP of the ARHGEF3 gene at 3p14.3 (rs1354034; meta-P-value = 7.35 x 10 -28 , Figures 2 and S4A, Table 2 ). ARHGEF3 encodes a Rho guanine nucleotide exchange factor, a catalyst of Rho GTPase conversion from inactive GDP-bound to active GTP-bound form. Rs1354034 was an eQTL for the majority of genes in the PM, all of which were in trans. An intergenic SNP, rs2836773 (meta-P-value = 5.4 x 10 -8 ), at the HLA locus was also identified as an mQTL for PM ( Figure S4B) . The ARHGEF3 mQTL (rs1354034) exhibited a strong trans-regulatory effect and was associated with 61 PM genes (65 unique probes) ( Table S8 ). The top trans eQTL was ITGB3 (meta-P-value = 5.09 x 10 -42 ), a gene encoding the β 3 subunit of the heterodimeric integrin receptor (integrin α IIb β 3 ). This integrin receptor is most highly expressed on activated platelets and plays a key role in mediating platelet adhesion and aggregation upon binding to fibrinogen and Willebrand factor (35, 36) . Our data are consistent with previous observations of the diverse trans eQTL effects of rs1354034 (23), including the putative splice-QTL effects of rs1354034 on TPM4, a significant eGene in the PM.
ARHGEF3 itself is of intense interest to platelet biology. It has previously been shown that silencing of ARHGEF3 in zebrafish prevents thrombocyte formation (37) . To test whether ARHGEF3 expression had an effect on PM genes, we regressed out ARHGEF3 levels and re-ran the eQTL analysis.
Adjusting for ARHGEF3 did not attenuate the trans-associations of rs1354034, suggesting either independence of downstream function for ARHGEF3 and rs1354034 or post-transcriptional modification of ARHGEF3. Previous GWAS studies have shown rs1354034 is associated with platelet count and mean platelet volume (37), however, perhaps due to power, we found no significant relationship between platelet counts and rs1354034 in YFS. While platelet counts were positively associated with the PM (β = 0.29; P-value = 8.23 x 10 -30 ) (Table S5) , the association between rs1354034 and the PM was still highly significant when conditioning on platelet counts (β = -0.33; Pvalue = 1.40 x 10 -17 ).
PM displayed diverse metabolic interactions and was associated with 55 metabolites, largely comprising of lipoprotein subclasses and fatty acids, as well as CRP (Figure 3 and Table S7 ).
Cholesterol esters in small HDL particles were most strongly associated with the PM (meta-P-value = 9.45 x 10 -20 ). HDL has been shown to exhibit antithrombotic properties by modulating platelet activation, aggregation and coagulation pathway (38) . On the other hand, pro-atherogenic lipoproteins effects on platelets has been recognised as an important driver in development of atherosclerosis. For example, LDL has been shown to influence platelet activity either by enhancing platelet responsiveness to aggregating stimuli or inducing aggregation (39, 40) . Moreover, LDL specific binding sites on platelets have also been reported (41, 42) . As noted above, the PM was associated with platelet counts, and adjustment of PM-metabolite associations for platelet counts in the YFS resulted in attenuation of approximately half of the weakest metabolite associations, however the strongest were maintained ( Table S6 ). Association with VLDL particle size and three others were gained following the adjustment (Table S6) .
Neutrophil module (NM)
Three loci were identified as mQTLs for NM (Figure 2 and Table 2 ). The top mQTL was intronic to LRRC8A at 9q34.11 (rs13297295; meta-P-value = 3.93 x 10 -11 , Figure S5A ). LRRC8A encodes for a trans-membrane protein shown to play a role in B and T cell development and T cell function (43, 44) .
Two additional intergenic mQTLs were located at the TAGAP locus at 6q25.3 (rs2485364; meta-Pvalue = 3.93 x 10 -9 ) and at 20q12 (rs140929198; meta-P-value = 1.41 x 10 -9 ) (Figures S5B-C).
Rs13297295 was a strong trans regulator of NM and was an eQTL for 8 NM genes (10 unique probes), in particular the major alpha defensins (DEFA1-DEFA4), the genes of highest centrality in the module (Table S8) . Rs13297295 was a cis-eQTL for another core NM gene, LCN2 (permuted meta-Pvalue = 1 x 10 -4 ) ( Table S8 ). LCN2 is expressed in neutrophils and inducible by TLR activation, acting as an antimicrobial agent via sequestration of bacterial siderophores to prevent iron uptake (45) (46) (47) .
LCN2's role in acute phase response appears to be related to cardiovascular diseases, such as heart failure (48) . At the TAGAP locus, rs2485364 was a trans-eQTL for 8 NM genes (10 probes) and was also a strong driver of LCN2 (meta-P-value = 9.11 x 10 -17 ) ( Table S8 ). Consistent with our findings, neutrophils from LCN2 deficient mice have been shown to have impaired chemotaxis, phagocytic capability, and increased susceptibility to bacterial and yeast infections compared to wild type (49, 50) .
This suggests a possible functional role of TAGAP variants in regulating neutrophil migration through
LCN2.
NM was associated with 121 circulating metabolites (~76% of all metabolites analysed) as well as CRP (Figure 3 and Table S7 ). The strongest is the previously reported association with inflammatory biomarker GlycA (meta-P-value = 2.68 x 10 -25 ) (10), however NM's association with various lipoprotein subclasses, particle sizes of lipoproteins, fatty acids, cholesterol, apolipoproteins, glycerides and phospholipids, amino acids, and other small molecules indicates it has a potentially major role in linking neutrophil function to metabolism.
Lipid-Leukocyte module (LLM)
Together with NM, the LLM showed extensive metabolic associations. Overall, 123 metabolites and CRP were associated with LLM, with the strongest being the ratio of triglycerides to phosphoglycerides (meta-P-value = 5.16 x 10 -138 , Figure 3 , Table S7 ). With the inclusion of the YFS, these findings strongly replicate previous LLM-metabolite associations (14) as well as highlight additional metabolite associations. We also confirm the previous strong negative association between CRP and LLM (meta-P-value = 8.16 x 10 -20 ). Consistent with previous studies, no mQTLs were detected for LLM.
General immune modules A and B (GIMA and GIMB)
No mQTLs were associated with GIMA and GIMB, however these modules were associated with 97 and 82 metabolites, respectively (Figure 3 and Table S7 ). Cholesterol esters in small HDL and the mean diameter for VLDL particles exhibited the strongest associations with GIMA (meta-P-value = 1.56 x 10 -30 ) and GIMB (meta-P-value = 1.83 x 10 -15 ), respectively. The GIMA was also associated with CRP (meta-P-value = 5.7 x 10 -5 ). Other metabolite associations with these two modules include mainly the VLDL and HDL subclass of lipoproteins and fatty acids, however, due to their large size and heterogeneous composition, interpretation of metabolic relationships of GIMA and GIMB is limited.
Long-term stability of interactions between metabolites, immune gene modules and mQTLs
The 216 individuals in both the DILGOM 2007 and 2014 follow-up allowed investigation of the longterm stability of immunometabolic and mQTL relationships. Across this seven-year period, the eight immune gene coexpression networks were strongly preserved (all preservation statistics' permutation P-values <0.001; Table S9 ). The metabolite-metabolite correlation structure was also largely consistent between DIGOM07 and DILGOM14 ( Figure S6 ).
Next, we examined how metabolite interactions with immune gene modules changed over the 7-year time period (Methods). The LLM-metabolite associations were the most consistent over time with 90 and 79 metabolites reaching significance in DILGOM07 and DILGOM14, respectively, of which 74 were significant at both time points ( Figure 4A , Table S10 ). The direction and effect size of LLMmetabolite associations were largely maintained ( Figure 4B) . For the neutrophil module, only the pyruvate association was significantly maintained over time, however there was some evidence that other expected NM-metabolite associations were stable over time, including GlycA (Table S10) .
While no metabolite associations were significantly maintained for platelet module, rs1354034 was a temporally stable mQTL of PM (mQTL P-value = 4.87 x 10 -7 ) . No other mQTLs reached significance for temporal stability.
Conclusions
This study has utilised over 2,000 individuals to map the immuno-metabolic crosstalk operating in circulation. We have identified and characterised eight robust immune gene modules, their genetic control and interactions with diverse metabolites, including many of clinical significance (e.g. triglycerides, HDL, LDL, branched-chain amino acids). Furthermore, our findings are consistent with and build upon those of previous studies. In addition to five newly identified gene modules, their mQTLs and metabolite interactions, we have replicated the previously characterised LL module and confirm its association with lipoprotein subclasses, lipids, fatty acids, and amino acids (13, 14) .
Associations between the core genes in the LL module and isoleucine, leucine, and various lipids were also identified independently in the KORA cohort (12) . Importantly, we have shown the long-term stability of LL and neutrophil module coexpression and metabolite interactions, and we have greatly expanded the number of known biomarkers associated with the NM from one (GlycA) to 123 (10) .
Our study has also expanded the widespread trans eQTL effects at the ARHGEF3 locus (23), shows them to be strongly maintained within individuals over time, and further identifies extensive lipoprotein and fatty acid metabolite interactions that may be a consequence of these trans effects.
Taken together, our analyses illustrate the rapidly growing body of evidence intimately linking the immunoinflammatory response to the blood metabolome. With finer-resolution maps of these interactions, new biomarkers of chronic and acute inflammatory states are likely to emerge. With in vivo and interventional studies, modulation of these metabolite-immune interactions through existing lipid-lowering medications, gut microbe effects or dietary changes may provide new ways the immune system itself can be utilised to lessen the burden of cardiometabolic disease.
Methods
Study Populations
This study used data from two population-based cohorts, the Dietary, Lifestyle, and Genetic determinant of Obesity and Metabolic syndrome (DILGOM; N=518) and the Cardiovascular Risk in Young Finns Study, (YFS; N=1,650), which have been described in detail elsewhere (13, 51) . All subjects enrolled in these studies gave written informed consent. The YFS is a longitudinal prospective cohort study that started in 1980, with follow-up studies carried out every three years, to monitor cardiovascular disease risk factors in children and adolescents from five major regions of Finland (Helsinki, Kuopio, Turku, Oulu, and Tampere). In the baseline study a total of 3,596 children and adolescents in age groups 3, 6, 9, 12, 15, and 18 years participated, who were randomly selected from the national public register, details of which are described in (51) . In this current study, data collected from the 2011 follow-up study (participants aged 34, 37, 40, 43, 46, and 49 years) were analysed. Ethics approval for the study research protocols was given by the Joint Commission on Ethics of Turku University and Turku University Central Hospital.
Sample Collection
Venous blood was collected following an overnight fast in all three studies. Samples were centrifuged, the resulting plasma and serum samples were aliquoted into separate tubes and stored at −70°C for analyses. Protocols for the blood sampling, physiological measurements, and clinical survey questions were similar across the YFS and DILGOM studies, and are described extensively in (13, 52) .
Genotyping and Imputation
Whole blood genomic DNA obtained from both cohorts was genotyped using the Illumina 610-Quad SNP array for DILGOM07 (N=555) (13) and a custom generated 670K Illumina BeadChip array for YFS (N=2,443) (53) . The 670K array shares 562,643 SNPs with the 610-quad array. The 670K array removes poorly performing SNPs from the 610-quad array and improves copy number variation coverage (53) . Genotype calling was performed with the Illuminus clustering algorithm (54) . Quality control was as previously described in (13) and (53) 
Metabolomics profiling
Metabolite concentrations for DILGOM07 (N=4,816), DILGOM14 (N=1,273), and YFS (N=2,046) were quantified from serum samples utilizing a high-throughput NMR metabolomics platform (Brainshake Ltd, Helsinki, Finland) (18, 55) . Details of the experimental protocol including sample preparation, NMR spectroscopy and metabolite identification has been previously described in (13, 18) .
A total of 158 metabolite measures were assessed, of which 148 were directly measured and 10 were derived ( Table S1) C-reactive protein (CRP), an inflammatory marker, was quantified from serum using a high sensitivity latex turbidimetric immunoassay kit (CRP-UL assay, Wako Chemicals, Neuss, Germany) and an automated analyser (Olympus AU400) in DILGOM07 (N=5000), DILGOM14 (N=1308), and YFS (N=2046). CRP levels were log2 transformed.
Gene expression, processing and normalization
Transcriptome-wide gene expression levels were quantified by microarrays from peripheral whole blood using similar protocols in all three cohorts, and have been previously described for DILGOM07 (13) and YFS (56) . Stabilised total RNA was obtained from whole blood using a PAXgene Blood RNA System and the protocols recommended by the manufacturer. In DILGOM07, RNA integrity and quantity was evaluated using an Agilent 2100 Bioanalyzer. In YFS, RNA integrity and quantity were evaluated spectrophotometrically using an Eppendorf BioPhotomer and the RNA isolation process was validated using an Agilent RNA 6000 Nano Chip Kit. RNA was hybridized to Illumina HT-12 version 3 BeadChip arrays in DILGOM07 and to Illumina HT-12 version 4 BeadChip arrays in DILGOM14 and YFS.
For DILGOM07, data was preprocessed as described in Inouye et al. (13) . Briefly, for each array the background corrected probes were subjected to quantile normalization at the strip-level. Technical replicates were combined by bead count weighted average and replicates with Pearson correlation coefficient < 0.94 or Spearman's rank correlation coefficient < 0.60 were removed. Expression values for each probe were then log2 transformed. For YFS, background corrected probes were subjected to quantile normalization followed by log2 transformation. For DILGOM14, probes matching to the erythrocyte globin components (N=4) and those that hybridized to multiple locations spanning more than 10Kb (N=507) were removed. Probes with average bead intensity of 0 were treated as missing.
The average bead intensity was then log2 transformed and quantile normalized. A total of 35,425 (for DILGOM07), 36,640 (for DILGOM14) and 37,115 (for YFS) probes passed quality control.
Gene co-expression network analysis and replication
Gene co-expression network modules were identified in DILGOM07 (N=518 individuals with gene expression data) as previously described (10) using WGCNA version 1.47 (57, 58) on all probes passing quality control. Briefly, probe co-expression was calculated as the Spearman correlation coefficient between each pair of probes, adjusted for age and sex. The weighted interaction network was calculated as the element-wise absolute co-expression exponentiated to the power 5. This power was selected through the scale-free topology criterion (57) , which acts as a penalization procedure to enhance differentiation of signal from noise. Probes were subsequently clustered hierarchically (average linkage method) by topological overlap dissimilarity (57) and modules were detected through dynamic tree cut of the resulting dendrogram with default parameters and a minimum module size of 10 probes (59) . Similar modules were merged together in an iterative process in which modules whose eigengenes clustered together below a height of 0.2 were joined. Module eigengenes, representative summary expression profiles, were calculated as the first eigenvector from a principal components analysis of each module's expression data.
Module reproducibility and longitudinal stability were assessed in YFS (N=1,650 with gene expression data) and DILGOM14 (N=333 with gene expression data) respectively using the NetRep R package version 0.30.1 (19) . Briefly, a permutation test (20,000 permutations) of seven module preservation statistics was performed for each module in YFS and DILGOM14 separately. These statistics test the distinguishability and similarity of network features (density and connectivity) for each module in a second dataset (20) . Modules were considered reproducible where permutation P-values for all seven statistics were < 0.001 (Bonferroni correcting for 40 modules) in YFS, and modules were considered longitudinally stable where P-values were < 0.001 for all seven statistics in DILGOM14. Probe coexpression in YFS was calculated as the Spearman correlation coefficient between age and sex adjusted expression levels and the weighted interaction network was calculated as the element-wise absolute co-expression exponentiated to the power 4 as previously described (10) . Probe co-expression in DILGOM14 was calculated as the Spearman correlation coefficient between each pair of probes, and the weighted interaction network defined as the element-wise absolute co-expression exponentiated to the power 5.
To filter out genes spuriously clustered into each module by WGCNA we performed a two-sided permutation test on module membership (Pearson correlation between probe expression and the module eigengene) for each reproducible module in DILGOM07 and YFS. Here, the null hypothesis was, for each module, that its probes did not truly coexpress with the module. The null distribution of module membership for each module was empirically generated by calculating the membership between all non-module genes and the module's eigengene. P-values for each probe were then calculated using the following permutation test P-value estimator (60):
Where b is taken as the number of non-module genes with a membership smaller or greater than the test gene's module membership, whichever number is smaller. v, the number of permutations calculated, and v t , the total number of possible permutations, are both the number of non-module genes. The resulting P-value was multiplied by 2 because the test was two-sided. To adjust for multiple testing, false discovery rate (FDR) correction was applied to the P-values separately for each module using the Benjamini and Hochberg method (61) . We rejected the null hypothesis at FDR adjusted P-value < 0.05 in both DILGOM07 and YFS, deriving a subset of core probes for each module.
Functional annotation of immune modules
Immune modules were identified through over-representation analysis of Gene Ontology (GO) terms in the core gene set for each of the 20 reproducible modules using the web based tool GOrilla (21) with default parameters (performed March 2016). GOrilla was run on two unranked gene lists where core module genes were given as the target list and the background list was given as the 25,233 human
RefSeq genes corresponding to any probe(s) passing quality control in both DILGOM07 and YFS. A hypergeometric test was calculated to test whether each module was significantly enriched for genes annotated for each GO term in the "Biological Process" ontology. A GO term was considered significantly over-represented in a module where its FDR corrected P-value was < 0.05. FDR correction was applied in each module separately. Significant GO terms for each module were further summarised into a subset of representative GO terms with REVIGO (22) using the RELSIM semantic similarity measure and a similarity cut-off value C = 0.5 on genes from Homo sapiens. A module was considered to be immune-linked where the representative GO term list contained the parent GO term GO:0002376 (immune system process) and/or GO:0002682 (regulation of immune system processes).
Statistical Analyses
Reproducible (63) . P-values for each association in DILGOM07 and YFS were combined in a meta-analysis using the METAL software (64) , which implements a sample size weighted Z-score method. A SNP was considered an mQTL if meta-analysis P-value (meta-P-value) was < 5 x 10 -8 . Blood cell count data available for YFS was utilized to test the robustness of module associations with mQTLs, where the same model was run with and without adjusting for leukocyte and platelet cell counts.
Significant mQTLs were subsequently tested as expression quantitative trait loci (eQTLs) for genes within their respective modules using Matrix eQTL in both DILGOM07 and YFS (65) . Both cis (mQTL within 1Mb of a given probe) and trans (mQTL greater than 5Mb from a given probe or on a different chromosome) associations were tested. Associations were tested using a linear regression model of probe expression on minor allele dosage (additive model) of the mQTL. Models were adjusted for age, sex, and the first 10 genetic PCs. For trans-eQTL associations P-values in DILGOM07 and YFS were combined in a meta-analysis using the weighted Z-score method and considered significant where the meta-P-value < 5x10 -8 . For cis-eQTL associations, permutation tests were performed in which gene expression sample labels were shuffled 10,000 times to compute an empirical P-value. The permuted model P-values and nominal P-value were combined across DILGOM and YFS07 in meta-analyses using the weighted Z-score method when computing the permutation test P-value. An mQTL was considered a cis-eQTL where the permutation test P-value < 0.05. Table S1 for full metabolite descriptions. (66)); surface receptors (IL2RB, SLAMF6, CD8A, CD8B, CD2, CD247, KLRD1, KLRG1 (66-68)); T and NK cell differentiation (ID2 and EOMES (69,70)), activation (ZAP70 and CBLB (71,72)), and recruitment (CX3CR1, CCL5, CCL4L2 (73)).
Figure legends
Viral response module (VRM 95 (88) Response to virus Type I interferon signaling pathway Response to biotic stimulus Type I interferon-induced antiviral activity (IFITM1, IFIT1, IFIT2, IFIT3, IFIT5, IFI44, IFI44L, IFI6, MX1, ISG15, ISG20, HERC5 (74,75)); viral RNA degradation (OAS1, OAS2, OAS3, OASL, DDX60 (31)); type 1 interferon-signalling pathway (IRF9, STAT1, STAT2 (76, 77) ). 
